Exercise May Boost Immune Response to Flu Vaccine
Physical activity and acute exercise offer some benefit for influenza vaccination response, according to a review published online.
Vaccination
The Case for Expanding Pharmacists’ Authority to Administer Vaccines
Dr Robert Popovian discusses access to immunization services among adults in low-income communities and efforts to expand pharmacists’ authority to administer vaccines to increase vaccination rates for this vulnerable population.
Vaccination Status Affects Patient Willingness to Have Surgery During Pandemic
Patient and hospital staff’s vaccine status may influence patients’ willingness to undergo a surgery during a pandemic.
Concomitant Flu Vaccine, COVID-19 Booster in Older Adults: Safety, Immunogenicity
A phase 2 study assessed safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine with a mRNA-1273 vaccine booster dose in older adults.
Risk of Bias in Test-Negative Studies on COVID-19, Influenza Vaccine Effectiveness
Researchers evaluated the risk of confounding bias in simulated test-negative studies that assessed estimated COVID-19 and influenza vaccine effectiveness.
Has the COVID-19 Pandemic Disrupted Routine Immunization Services?
As the medical field shifted its priorities to treating COVID-19 at the start of the pandemic, routine immunization was one of the many medical fields to experience disruption. What was the scope of this disruption and what are possible ways to address it?
Vaccination Coverage in Kindergarteners Decreased in 2020 to 2021 School Year
Compared with the 2019 to 2020 school year, vaccination coverage among children in kindergarten decreased by about 1 percent for all vaccines in the 2020 to 2021 school year.
Flu Vaccine Effective Against Life-Threatening Illness in Children
Vaccine effectiveness 75 percent during 2019 to 2020 season, when vaccine-mismatched viruses predominated
No Detectable Association Between mRNA COVID-19 Vaccines and Facial Paralysis
While several cases of facial paralysis were observed during the phase 3 clinical trials of the mRNA COVID-19 vaccine, a causal relationship could not be established. With the US Food and Drug Administration recommending monitoring of vaccine recipients, the researchers looked at a disproportionality analysis using the WHO’s pharmacovigilance database, VigiBase.
- Loading...
Loading...
Next post in Lung Infection
Loading... 
Loading...